These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21446895)

  • 1. Copayment level, treatment persistence, and healthcare utilization in hypertension patients treated with single-pill combination therapy.
    Yang W; Kahler KH; Fellers T; Orloff J; Chang J; Bensimon AG; Wu EQ; Fan CP; Yu AP
    J Med Econ; 2011; 14(3):267-78. PubMed ID: 21446895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O; Andrews LM; Wang L; Xie L
    J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care.
    Taira DA; Wong KS; Frech-Tamas F; Chung RS
    Am J Manag Care; 2006 Nov; 12(11):678-83. PubMed ID: 17090224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy.
    Malesker MA; Hilleman DE
    Manag Care; 2010 Jul; 19(7):36-42. PubMed ID: 20672530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany.
    Breitscheidel L; Ehlken B; Kostev K; Oberdiek MS; Sandberg A; Schmieder RE
    J Med Econ; 2012; 15(1):155-65. PubMed ID: 22035215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives.
    Yang W; Chang J; Kahler KH; Fellers T; Orloff J; Wu EQ; Bensimon AG
    Curr Med Res Opin; 2010 Sep; 26(9):2065-76. PubMed ID: 20629600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic impact of switching from valsartan to other angiotensin receptor blockers in patients with hypertension.
    Signorovitch J; Zhang J; Wu EQ; Latremouille-Viau D; Yu AP; Dastani HB; Kahler KH
    Curr Med Res Opin; 2010 Apr; 26(4):849-60. PubMed ID: 20141381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
    Patel BV; Remigio-Baker RA; Thiebaud P; Preblick R; Plauschinat C
    BMC Fam Pract; 2008 Nov; 9():61. PubMed ID: 18990240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economics of suboptimal drug use: cost-savings of using JNC-recommended medications for management of uncomplicated essential hypertension.
    Xu KT; Moloney M; Phillips S
    Am J Manag Care; 2003 Aug; 9(8):529-36. PubMed ID: 12921230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.
    Cole JA; Norman H; Weatherby LB; Walker AM
    Pharmacotherapy; 2006 Aug; 26(8):1157-64. PubMed ID: 16863491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence with treatment in newly treated middle-aged patients with essential hypertension.
    Perreault S; Lamarre D; Blais L; Dragomir A; Berbiche D; Lalonde L; Laurier C; St-Maurice F; Collin J
    Ann Pharmacother; 2005 Sep; 39(9):1401-8. PubMed ID: 16076920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors.
    Schneeweiss S; Walker AM; Glynn RJ; Maclure M; Dormuth C; Soumerai SB
    N Engl J Med; 2002 Mar; 346(11):822-9. PubMed ID: 11893794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.
    Bourgault C; Elstein E; Le Lorier J; Suissa S
    CMAJ; 1999 Aug; 161(3):255-60. PubMed ID: 10463046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S401-13. PubMed ID: 12416790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
    Machnicki G; Ong SH; Chen W; Wei ZJ; Kahler KH
    Curr Med Res Opin; 2015 Dec; 31(12):2287-96. PubMed ID: 26397178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension.
    Dezii CM
    Manag Care; 2000 Sep; 9(9 Suppl):2-6. PubMed ID: 11729417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of statin copayments on adherence and medical care utilization and expenditures.
    Gibson TB; Mark TL; Axelsen K; Baser O; Rublee DA; McGuigan KA
    Am J Manag Care; 2006 Dec; 12 Spec no.():SP11-9. PubMed ID: 17173486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive persistence and drug class.
    Marentette MA; Gerth WC; Billings DK; Zarnke KB
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study.
    Erkens JA; Panneman MM; Klungel OH; van den Boom G; Prescott MF; Herings RM
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):795-803. PubMed ID: 16178043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between prescription copayment levels and β-blocker medication adherence in commercially insured heart failure patients 50 years and older.
    Patterson ME; Blalock SJ; Smith AJ; Murray MD
    Clin Ther; 2011 May; 33(5):608-16. PubMed ID: 21665045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.